| 标题: |
An open-label phase 1b/2 study of surufatinib in combination with tislelizumab in subjects with advanced solid tumors 索凡替尼联合替雷利珠单抗治疗晚期实体瘤患者的开放标签的Ib/II期临床研究 |
| 主要作者: | Arvind Dasari, MD, MS, MD Anderson Cancer Center |
| 会议环节: | 海报展示︰发展疗法 – 免疫疗法 |
| 摘要编号: | TPS2677 |